Look forward to discussing! Huge thanks to Stephanie Dudzinski for organizing and ACRO - American College of Radiation Oncology for the opportunity.

Our article “Patient-Reported Outcomes as a Recruitment Strategy for Clinical Trial Enrollment” is out today in JAMA Oncology. Thank you Erin Gillespie, MD MPH Jun J. Mao for letting me be involved in this and everyone who assisted 😊 Kaitlyn Lapen

Thank you kristac and Stanford Medicine for highlighting our recent work in Nature Cancer investigating the soft tissue #sarcoma microenvironment!
med.stanford.edu/news/all-news/…

🎉We are thrilled to announce our incredible #MATCH2024 doctors!

So lucky to welcome you into our Stanford Radiation Oncology
family!

Allison Zhong UC San Diego School of Medicine
Nicholas Verdini Tufts School of Medicine
Jennifer Matsui The Ohio State University College of Medicine
erroncollins Morehouse College Morehouse School of Medicine

#MATCHDAY Stanford Radiation Oncology Residents

So thrilled to match to my top choice Stanford Radiation Oncology and return to my home state of CA! Forever grateful for my husband, daughter, family & friends. Huge thanks to all my mentors (especially Joshua D. Palmer, MD Everett Moding, MD, PhD & Dr. McGovern). So excited to join this amazing field!

Excellent start today ⁦SNO⁩ with great talk by ⁦Joshua D. Palmer, MD⁩ on use of DOTATATE PET as a biomarker for response for meningiomas, improve RT target delineation, and optimize pt selection for surveillance ⁦OhioStateRadOnc⁩ ⁦⁦⁦The James⁩

Had an amazing time at #ASTRO2023 ! Met some incredible people and caught up with old friends. Big thanks to Joshua D. Palmer, MD Haley K. Perlow, MD and Dr. Susan McGovern who made the presented research possible 🙌

Exciting to see so many people staying back at #ASTRO23 all the way till the last day, last session! Maybe everyone was waiting to listen to my talk? 🤣 Great discussion though, thanks to other presenters, moderators, and the audience. Jona Hattangadi-Gluth, MD Jennifer Matsui Shearwood McClelland III, M.D. Bismarck Odei MD

Strong work informing practice from the PROPS-BM, we are grateful to have been involved. Our group has utilised fractionated preop as the SOC for years and nice to see the data. This also informed our practice to cut down our margin to 1mm. redjournal.org/article/S0360-…. ASTRO

Excellent editorial on thoughtful use of smaller margins for GBM
Dan Trifiletti, MD Michael Milano Kristin Redmond Dr. Pollum Jona Hattangadi-Gluth, MD Michelle Kim
redjournal.org/article/S0360-…

Thank you Kerri Reeves and Applied Radiation Oncology for highlighting our ongoing MRI only simulation trial for brain metastasis. Hyeri Lee, PhD, DABR is helping to lead these efforts. We are hopeful this can help improve the workflow and quality of life for patients. appliedradiationoncology.com/articles/synth…

Grateful to have the opportunity to be involved in this work 😊

Check out our teams latest paper on what I like to call Memory Avoidant WBRT (MA-WBRT) we hope to improve upon HA-WBRT in our phase 2 trial. advancesradonc.org/article/S2452-…

Don’t forget to sign up 💻 for this excellent networking session! Tag your current medical students applying to #radonc #match2024 to make sure they don’t miss out on this rad event ☢️

Strong work by our stellar medical student and future rad onc superstar Jennifer Matsui. Prognostic factors in grade 4 gliomas in Peds, AYA. Collab with MD Anderson Susan McGovern and The James link.springer.com/article/10.100…

Heard about so many exciting translational and clinical research projects at the Pediatric SNO Conference in Washington DC 🙌 Spotted both my mentors Dr. Joshua Palmer Joshua D. Palmer, MD and Dr. Susan McGovern in attendance! #SNOPeds

Enjoyed a fun hike in Hocking Hills with visiting medical students from Fukushima Medical University! Also loved working with them in the The Ohio State University Wexner Medical Center rad onc department ☢️

Study of pts w/brain mets (BMs) from solid tumors who received stereotactic radiosurgery before surgery for BMs showed low rates of local recurrence, adverse radiation effects, or meningeal disease; tumor & treatment factors were assoc w/greater risk ja.ma/3qnQjRN